Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19

Name: Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19
License: Public Domain

Tor Biering-Sørensen

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

covid

covid-19

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 311177
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.